Sutro Biopharma reported revenue of $9.84M and net income of -$38.53M for the quarter ended Jun 2026, down 43.5% year over year. This income statement covers 36 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2016 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||
| Revenue | 28.05M | 8.52M | 10.65M | 5.90M | 28.10M | 25.15M | 8.63M | 12.67M | 10.41M | 16.92M | 113.72M | 13.01M | 25.71M | 8.52M | 14.81M | 17.40M | 63.74M | 9.69M | 6.60M | 9.84M | ||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 25.31M | 26.60M | 29.93M | 29.99M | 32.33M | 31.71M | 43.13M | 39.40M | 41.59M | 45.67M | 53.77M | 56.88M | 62.02M | 62.11M | 71.04M | 51.60M | 38.33M | 39.85M | 36.64M | 31.70M | ||||||||||||||||
| Selling, General & AdministrativeSG&A | 12.54M | 16.59M | 15.76M | 15.04M | 15.14M | 14.64M | 14.72M | 15.51M | 15.00M | 15.27M | 16.80M | 12.72M | 12.37M | 14.33M | 9.03M | 13.27M | 10.34M | 8.74M | 8.66M | 7.83M | ||||||||||||||||
| Restructuring CostsRestructuring | 21.04M | 18.42M | 9.56M | 4.39M | 0.20M | |||||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -1.55M | |||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 37.85M | 43.19M | 45.69M | 45.03M | 47.48M | 46.36M | 57.85M | 54.91M | 56.59M | 60.94M | 70.57M | 69.60M | 74.39M | 76.44M | 80.07M | 85.91M | 67.09M | 58.15M | 49.70M | 39.73M | ||||||||||||||||
| Operating IncomeOp. Inc | -9.80M | -34.67M | -35.04M | -39.13M | -19.38M | -21.21M | -49.22M | -42.24M | -46.18M | -44.01M | 43.15M | -56.59M | -48.69M | -67.92M | -65.26M | -68.51M | -3.35M | -48.46M | -38.05M | -29.89M | ||||||||||||||||
| EBIT | -9.80M | -34.67M | -35.04M | -39.13M | -19.38M | -21.21M | -49.22M | -42.24M | -46.18M | -44.01M | 43.15M | -56.59M | -48.69M | -67.92M | -65.26M | -68.51M | -3.35M | -48.46M | -38.05M | -29.89M | ||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.85M | 0.82M | 0.61M | 0.66M | 0.59M | 2.79M | ||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.17M | 0.11M | -3.62M | -0.66M | -0.59M | -2.79M | 7.49M | -2.99M | -2.92M | 4.55M | 4.56M | 4.10M | 4.91M | 22.17M | -0.90M | 3.19M | 2.52M | 2.01M | 1.53M | 1.72M | ||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | ||||||||||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -1.62M | 0.68M | 19.13M | -4.83M | -7.45M | -8.17M | -8.40M | -8.79M | -8.64M | |||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||
| EBT | -6.15M | -30.90M | -38.12M | -39.11M | -23.51M | -19.49M | -34.59M | -49.66M | -38.37M | -47.45M | 46.87M | -58.21M | -48.01M | -48.79M | -70.09M | -65.33M | -11.52M | -56.86M | -46.84M | -38.53M | ||||||||||||||||
| Tax ProvisionsTaxes | 2.50M | 0.40M | 0.15M | 1.84M | 15.81M | 0.01M | 2.39M | -0.02M | -40.14M | 0.00M | ||||||||||||||||||||||||||
| Profit After TaxPAT | -6.15M | -30.90M | -38.12M | -39.11M | -26.01M | -19.49M | -34.59M | -50.05M | -38.52M | -49.28M | 31.07M | -58.21M | -48.02M | -48.79M | -72.44M | -75.97M | -11.50M | -56.86M | -46.76M | -38.53M | ||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -6.15M | -30.90M | -38.12M | -39.11M | -26.01M | -19.49M | -34.59M | -50.05M | -38.52M | -49.28M | 31.06M | -58.21M | -48.02M | -48.79M | -72.48M | -65.33M | -11.50M | -56.86M | -6.71M | -38.53M | ||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -6.15M | -30.90M | -38.12M | -39.11M | -26.01M | -19.49M | -34.59M | -50.05M | -38.52M | -49.28M | 31.06M | -58.21M | -48.02M | -48.79M | -72.48M | -65.33M | -11.50M | -56.86M | -6.71M | -38.53M | ||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -6.15M | -30.90M | -38.12M | -39.11M | -26.01M | -19.49M | -34.59M | -50.05M | -38.52M | -49.28M | 31.06M | -58.21M | -48.02M | -48.79M | -72.48M | -65.33M | -11.50M | -56.86M | -6.71M | -38.53M | ||||||||||||||||
| Net Income towards Common StockholdersNet Income | -6.15M | -30.90M | -38.12M | -39.11M | -26.01M | -19.49M | -34.59M | -50.05M | -38.52M | -49.28M | 31.06M | -58.21M | -48.02M | -48.79M | -72.48M | -65.33M | -11.50M | -56.86M | -6.71M | -38.53M | ||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -1.33 | -6.69 | -8.27 | -8.41 | -5.54 | -3.72 | -6.82 | -8.52 | -6.38 | -8.13 | 5.16 | -9.47 | -5.91 | -5.95 | -9.43 | -7.86 | -1.36 | -6.70 | -0.79 | -2.33 | ||||||||||||||||
| EPS (Diluted) | -1.33 | -6.69 | -8.27 | -8.41 | -5.54 | -3.72 | -6.82 | -8.52 | -6.38 | -8.13 | 5.16 | -9.47 | -5.91 | -5.95 | -9.43 | -7.86 | -1.36 | -6.70 | -0.79 | -2.33 | ||||||||||||||||
| Shares Outstanding | 4.61M | 4.62M | 4.61M | 4.65M | 4.70M | 5.23M | 5.07M | 5.87M | 6.03M | 6.06M | 6.02M | 6.15M | 8.12M | 8.20M | 7.68M | 8.31M | 8.46M | 8.49M | 8.50M | 16.57M | ||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 4.61M | 4.62M | 4.61M | 4.65M | 4.70M | 5.23M | 5.07M | 5.87M | 6.03M | 6.06M | 6.02M | 6.15M | 8.12M | 8.20M | 7.68M | 8.31M | 8.46M | 8.49M | 8.50M | 16.57M | ||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 4.61M | 4.63M | 4.63M | 4.69M | 4.87M | 5.46M | 5.75M | 6.02M | 6.05M | 6.09M | 6.10M | 6.25M | 8.19M | 8.24M | 8.25M | 8.43M | 8.47M | 8.51M | 8.58M | 16.58M | ||||||||||||||||
| EBITDA | -9.80M | -34.67M | -35.04M | -39.13M | -19.38M | -21.21M | -49.22M | -42.24M | -46.18M | -44.01M | 43.15M | -56.59M | -48.69M | -67.92M | -65.26M | -68.51M | -3.35M | -48.46M | -38.05M | -29.89M | ||||||||||||||||
| Interest ExpensesInt Expense | 0.85M | 0.82M | 0.61M | 0.66M | 0.59M | 2.79M | ||||||||||||||||||||||||||||||
| Tax Rate | -10.63% | -0.80% | -0.39% | -3.88% | 33.74% | -0.02% | -3.41% | 0.16% | 85.68% | 0.00% |